vall d'hebron

Teams of scientists from two hospitals in Catalan capital publish work showing potential breakthroughs in cancer and heart treatments

Using more advanced technology, professionals will be able to respond better to patients' needs at Vall d'Hebron facility

Barcelona Vall d'Hebron hospital takes part in research revealing new genetic regions that relate cannabis consumption with schizophrenia

Researchers at the Vall d’Hebron hospital VHIO center uncover new function of already-known HMGA1

Catalan News speaks with Héctor G Palmer regarding findings of Vall d’Hebron Institute of Oncology

VHIO find how some tumoral cells go into hiding and emerge later to cause the disease

Vall d’Hebron Institute of Oncology presents study at ASCO meeting in Chicago

The health center predicts treating up to 80 patients in 2018 with this new robotic surgery

The Abernethy deformity affects one out of 30,000 children and causes severe complications

The Vall d’Hebron Hospital in Barcelona, one of the pioneer hospitals worldwide in non-invasive surgery in children, is planning to use minimally invasive methods with 70 percent of its pediatric surgeries. This week various pediatric surgery specialists gathered in a congress at the Vall d’Hebron Hospital Campus to share their professional expertise. The Vall d’Hebron Hospital is one of the few hospitals capable of performing surgery on a newborn with a weight of less than 1.5 kilograms or on a 24 week-old fetus with spine bifida. Since the incorporation of Doctor Manuel López as Head of Services, pediatric laparoscopy has gotten a new boost. López has set the objective of performing the majority of the 2000 annual surgeries on children with innovative methods.

80 years after the Spanish Civil War broke out, there are still 4,912 missing victims and more than 5,000 families continue to search for their relatives. The Hospital Vall d'Hebron in Barcelona has started to perform genetic tests on relatives of the missing in order to identify remains buried in mass graves. In the past two weeks, specialists have taken samples of the saliva of 80 elderly people in Barcelona. Most of them are siblings or children of the victims of the Franco regime. Isabel Domènech, a 79 year-old resident of Santa Coloma de Gramenet (a municipality near Barcelona), was two years old when her father died at the end of the Civil War. She has been looking for him for many years and claims her right to know where his remains rest: “it is the minimum we ask for”. The DNA profiling programme announced by the Catalan Government last September has requested more than 1,100 people to do these tests throughout the four Catalan provinces. The genetic profiles obtained will be cross-referenced with samples from the remains found and those which are still yet to be found in mass graves.  

The surgical facilities at the Vall d’Hebron Hospital in Barcelona were created in the 50’s. Now, half of a century later, the hospital has launched a new surgical ward for highly complex surgery. It has 10,000 square metres and 19 operating theatres with cutting-edge technology. The coordinator of surgical activity, Joan Anton Huete, said that the new block will admit “a larger number of patients” and, therefore, waiting lists will be reduced. The Hospital expects to conduct more and better operations, because the surgery will be less aggressive, a fact that can make the postoperative care easier and shorten the hospitalisation period. The new surgical block has represented an investment of €37 million.

Catalonia has established a reputation as a global centre of scientific excellence, pioneering research and innovative ideas. This corner of Europe, with just 0.1% of the world’s population, accounts for nearly 1% of global scientific production. The Catalan Research system, formed of 12 internationally esteemed universities, over 60 research centres, 15 world class hospitals, and almost 9,000 innovative companies, attests to the Catalonia's ambitions in science. This territory is also a magnet of international funding: with 1.5% of Europe’s population, it receives 2.2% of European competitive funds and 3.5% of European Research Council (ERC) grants. There can be no doubt that Catalonia is now a benchmark in Southern Europe, producing frontier research and punching considerably above its weight in terms of scientific contribution.  It is attracting worldwide talent and projects, and many consider it to be fast becoming the Palo Alto of biomedical research.

A clinical trial conducted in nine Catalan health care centres and published in the ‘British Medical Journal’ found that “in the case of mild respiratory infections such as acute bronchitis, there is a misuse of antibiotics, which is of no benefit to patients, and only helps increasing resistance to these drugs”. The study has been coordinated by the prestigious Vall d’Hebron Research Institute (VHIR). From 2010 to 2012, 416 patients, who showed several signs of acute bronchitis, were randomly assigned one of three different treatments. The main conclusion was that antibiotics, the most widely prescribed treatment for this type of illness, are ineffective. The study also showed that anti-inflammatory treatments increased in a minimal way the chances of ending coughs faster.

Doctor Joan Massagué has been appointed Scientific Director of the Sloan-Kettering Institute in New York , the world’s leading cancer research centre, which is part of the Memorial Sloan-Kettering Cancer Centre. The Catalan scientist has been chosen by an international expert committee and will take office on the 1^st of January 2014. The President and CEO of the Memorial Sloan-Kettering, Craig B. Thomson, said that Massagué had been given the job for his “exemplarity as a scientist” and because he is an “international leader” in the study of metastasis and factors regulating cell growth. This announcement follows last year’s appointment of another Catalan Doctor, Josep Baselga, as the Physician-in-Chief of the Memorial Sloan-Kettering Cancer Centre. Both Baselga and Massagué will continue to combine their responsibilities in New York with their research in Barcelona.